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Background: The efficacy and safety of rigid pericardial endoscopy as the promising minimally invasive approach
to the pericardial space was evaluated. Techniques for cell transplantation, epicardial pacemaker lead implantation,
and epicardial ablation were developed.
Methods: Two swine and 5 canines were studied to evaluate the safety and efficacy of rigid pericardial endoscopy.
After a double pericardiocentesis, a transurethral rigid endoscope was inserted into the pericardial space. The
technique to obtain a clear visual field was examined, and acute complications such as hemodynamic changes and
the effects on intra-pericardial pressure were evaluated. Using custom-made needles, pacemaker leads, and forceps,
the applications for cell transplantation, epicardial pacemaker lead implantation, and epicardial ablation were also
evaluated.
Results: The use of air, the detention of a stiff guide wire in the pericardial space, and the stretching of the
pericardium with the rigid endoscope were all useful to obtain a clear visual field. A side-lying position also aided
observation of the posterior side of the heart. As a cell transplantation methodology, we developed an
ultrasonography-guided needle, which allows for the safe visualization of transplantation without major
complications. Pacemaker leads were safely and properly implanted, which provides a better outcome for cardiac
resynchronizing therapy. Furthermore, the success of clear visualization of the pulmonary veins enabled us to
perform epicardial ablation.
Conclusions: Rigid pericardial endoscopy holds promise as a safe method for minimally invasive cell
transplantation, epicardial pacemaker lead implantation, and epicardial ablation by allowing clear visualization of
the pericardial space.
Keywords: Rigid pericardial endoscopy, Minimally invasive surgery, Cell transplantation, Epicardial pacemaker lead
implantation, Epicardial ablationBackground
Although tissue engineering research has developed vari-
ous techniques to establish stem cell differentiation, there
have been no established techniques to transplant these
resources. The intracoronary infusion of cell resources has
been clinical used for acute myocardial infarction [1],* Correspondence: kimura@z7.keio.jp
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reproduction in any medium, provided the orischemic heart disease [2], and nonischemic cardiomyop-
athy [3]. However, this approach faced major complications
due to microvascular embolization [4]. Intramyocardial de-
livery, which is a direct injection into the myocardium, is
more beneficial in cell retention and therapeutic effects
compared to systemic, intracoronary, or intravenous infu-
sion methods [4,5]. It can be achieved by a transepicardial
or transendocardial approach [6]. Transepicardial delivery
is usually performed by way of a sternotomy duringLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[8], or coronary sinus [9]. Transendocardial delivery
requires a retrograde left ventricular approach via the
femoral artery [10]. For this purpose, the NOGA XP
Cardiac Navigation system™ (Biologics Delivery Systems
Group, Cordis Corporation, Diamond Bar, CA, USA)
[11] and the MyoStar™ catheter (BiosenseWebster,
Diamond Bar, CA, USA) [12] are used as cell delivery
navigation systems. These systems allow recognition
of the specific areas upon which to deliver laser en-
ergy [13], genes [14], and cells [15] under magnetic
and electromechanical guidance; moreover, these
methods have been reported to be effective for ische-
mic [16] and nonischemic disease [17]. However, there
is still a risk of microvascular embolization [18], and
the limitations due to positional errors during mapping
remain to be solved.
Therefore, we have evaluated the feasibility of flexible
pericardial endoscopy as a minimally invasive intramyo-
cardial delivery method with direct visualization of the
pericardial space [19]. The flexible endoscope was
inserted from the subxyphoid area by using the Seldinger
technique under fluoroscopic guidance. The small peri-
cardial space was inflated by air to obtain a clear visual
field to maintain a certain distance between the endo-
scope and the heart. The flexible pericardial endoscope
led to no acute or chronic complications. Too much air
in the pericardial space induced transient blood suppres-
sion, which was called “air tamponade”. This was imme-
diately resolved by suctioning the excess air. The
endoscopic image was so vivid no other guidance sys-
tems were necessary for minor surgery applications.
Direct endoscopic imaging is free from the limitations
of mapping error and can be a promising technique for
minor surgery in the pericardial space. To explore these
advantages and to establish pericardial endoscopic
surgery, we evaluated the use of rigid pericardial endos-
copy for a better visual field and easier access to the
pericardial space. In this study, we invented a safer
ultrasonography-guided cell transplantation system. We
focused on further optimization of epicardial approach
devices to treat arrhythmias, which included epicardial
pacemaker lead implantation and epicardial ablation.
Methods
All of the experimental protocols were approved by the
institutional ethical committee.
A double sheath puncture procedure
Five canines weighing 18–25 kg and 2 swine weighing
30–35 kg were studied. Following the infusion of 0.5
mg/kg pentobarbital, the animals were intubated and
ventilated with room air by a constant-volume cycled
respirator (Model SN-480-3, Shinano Inc., Tokyo, Japan).The animals were anesthetized with 1.5% halothane, and
a 50 ml/h normal saline infusion was used to compen-
sate for body fluid loss and drug delivery. The right fem-
oral arterial blood pressure, electrocardiogram, and
pulse oximetry were continuously monitored during the
procedures.
After local anesthesia, sheaths were placed in the peri-
cardial space by using the modified Seldinger technique
[19]. An 18 Gauge needle for epidural anesthesia was
used for percutaneous pericardiocentesis from the epi-
gastric fossa under ultrasonography and fluoroscopy
guidance. After safely puncturing the pericardium with a
puff of contrast medium, a guide wire (outer diameter
(OD) = 0.35 mm) was inserted into the pericardial space.
The cutaneous hole was gradually upsized by several
polypropylene dilators (8 French, 12 French). After-
wards, 2 types of sheaths, which are described below,
were inserted. For a double sheath maneuver, the second
sheath was inserted by repeating the same procedure.
The second puncture site was directed as far as possible
from the first site to avoid interference of both sheaths.
Device design
We used several types of rigid endoscopes, sheaths, nee-
dles, and forceps, as shown in Figure 1. These instru-
ments were designed as prototypes for rigid pericardial
endoscopic surgery.
Two kinds of rigid endoscopes (Model WA50373B
and A22003A, Olympus Medical Systems Corporation,
Tokyo, Japan) were used (Figure 1, R-30, R-70). These
endoscopes were originally designed for transurethral
resection of cancers. These endoscopes provided a 30°
(R-30) and a 70° (R-70) cross-eyed visual field. The R-30
endoscope provided a 70° viewing angle and the R-70
endoscope provided a 90° viewing angle. The viewing
angles were sufficiently wide to observe the surface of the
heart at close range. Other information, such as model
numbers, sizes, and specifications are shown in Figure 1.
We used 2 types of handmade sheaths: a smaller
sheath (Figure 1, Sh-S) for the rigid endoscopes and a
larger sheath (Figure 1, Sh-L) for forceps and needles.
The sheaths were fluoroscopically visible and were
equipped with a check valve to seal the air in the peri-
cardium. A clasp for the guide wire was also attached to
prevent the unintentional extraction of the guide wires.
We arranged 2 types of guide wires; a soft, plastic,
readymade guide wire was used for the Seldinger tech-
nique, which was later replaced by a stiff guide wire
(Radifocus™ Guide Wire M, Terumo Corporation,
Tokyo, Japan) that was detained inside of the pericardial
space and fixed by the wire clasp during sessions.
Two types of needles for cell transplantation were
designed by modifying abdominal forceps. A needle with
a grip (Figure 1, Nd-G) was inserted through Sh-L; this
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Model No. NA-201SX-4022, 22 Gauge
Figure 1 Characteristics of the devices for pericardial endoscopic surgery. We developed unique tools for pericardial endoscopic
maneuvers. The ID, name, specification, and figure of devices are shown. R-30 and R-70 were originally designed for transurethral cancer resection
with a 30 and 70° squinted visual field. Sh-L and Sh-S are 15 French and 22.5 French sized sheaths, respectively, with guide wires clamps. Nd-G is
the cell transplantation needle with a grip and Nd-U is visible under ultrasonography. Black scale: 1 cm; ID: inner diameter; OD: outer diameter;
PTFE: polytetrafluoroethylene.
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the metal forceps and connected to a syringe. By grasping
the grip, the needle extended 3–5 mm from the tip of the
forceps. Moreover, we developed an ultrasonography-
guided needle (Figure 1, Nd-U). The tip of the readymade
ultrasonographic needle (Model BF-UC180F, Olympus
Medical Systems Corporation, Tokyo, Japan) was
attached to the hard shaft, and a 23 Gauge needle
extended out from the probe. The probe could be curved
90° in either direction to position the probe on the sur-
face of the heart.Manipulation establishment and safety evaluation
After a double sheath insertion, the rigid endoscopes
were advanced through the Sh-S sheath, and forceps or
needles were inserted through Sh-L. The pericardial
space was inflated with air, as previously reported [19].
Optimization of the devices and maneuvers for a clearer
visualization of the pericardial space were performed.
Furthermore, a cell transplant demonstration, epicardial
pacemaker lead implantation, epicardial ablation, and a
safety evaluation of a continuous carbon monoxide supply
device were evaluated as described below. Complicationssuch as hemorrhages, arrhythmia, and hemodynamic data
were continuously monitored throughout the procedures.
Cell transplant demonstration
To simulate the clinical implications for cell transplant-
ation, 24 μm silicon beads (Catalog No.35-5B, Thermo
Scientific, Kanagawa, Japan) were transplanted by Nd-G
and Nd-U in 2 canines. The silicon beads were mixed
with indocyanine green, a contrast medium for fluoroscopy
(Iomeron™, Eizai Co.,Ltd., Tokyo, Japan), and a contrast
medium for ultrasonography (Levovist™, Bayer-Schering,
Berlin, Germany) to identify the infiltration in the myo-
cardium. A total of 5 ml of the beads medium (105-106
beads/mL) was transplanted by puncturing the myocar-
dium 20 times. After the procedure, the animals were
sacrificed and the hearts were evaluated macroscopically
and microscopically with a fluorescence filter (Model
PB0007, Asahi Spectra Co., Ltd. Tokyo, Japan).
Epicardial treatment for arrhythmia
In cardiac resynchronizing therapy, an epicardial ap-
proach with open chest surgery can be considered in
cases where appropriate positioning of pacing leads
via the coronary sinus is difficult. However, as a
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were implanted by rigid pericardial endoscopy. The
intraventricular pacing lead (Model 5076, Medtronic,
Minneapolis, MN, USA), the epicardial temporary
pacing lead (Model 6491, Medtronic, Minneapolis,
MN, USA) and the epicardial, sutureless, myocardial
lead (Model 5071–35, Medtronic, Minneapolis, MN,
USA) were used. The intraventricular pacing lead was
implanted with a deflectable stylet (Model 6094–58,
Medtronic, Minneapolis, MN, USA) and fixed in the
left ventricular free wall of the canines. The epicardial
temporary pacing lead was transplanted in the right
ventricle with a needle holder. Implantation of the epi-
cardial, sutureless, myocardial lead was attempted by
screwing the lead into the myocardium through a 14 mm
sized sheath in a swine. After implantation, the lead was
connected to the stimulator (Model 5348, Medtronic,
Minneapolis, MN, USA) and parameters of sensitivity
and pacing threshold were measured.
Furthermore, applications for epicardial ablation were
evaluated. Epicardial radiofrequency catheter ablation is
currently the established, intracardiac approach for in-
curable arrhythmia [20]. Attempts to obtain a clear
visualization of the heart to perform ablation were evalu-
ated in the canines. Complications caused by clamping
the pulmonary veins were monitored.
Intrapericardial pressure monitoring
A 60 kg swine was used to examine the relationship
between intrapericardial pressure and hemodymanics.
After a single pericardiocentesis, the continuous carbon
dioxide infusion device (Model UHI-3; Olympus Medical
Systems Corporation, Tokyo, Japan) used for pneumo-
peritoneum during laparoscopic surgery was connected
to 8 French sheaths. The intrapericardial pressure, vital
signs, fluoroscopy, and the amount of air during the pro-
cedure were monitored.
Results
Manipulation of pericardial endoscopic surgery
The manipulation of rigid pericardial endoscopes was
intuitive even for cardiologists; however, stretching the
pericardium with endoscopes and managing body position
were important to clearly visualize the narrow pericardial
space.
First, a rigid endoscope was inserted into Sh-S from
the epicardial fossa to obtain the antero-posterior caudal
view. This enabled us to look up the anterior base of the
heart from the apical position. Stretching the pericar-
dium by moving the endoscope like a lever allowed us to
enlarge the space between the pericardium and the heart
so that a better overview of the wide area of the heart
could be obtained. By rotating the shaft of the endo-
scope, both sides of the lateral wall of the heart wereobserved. The base of the ventricles, atrial appendages
and atriums were confirmed by carefully advancing the
endoscopes. To observe the posterior and lateral sides of
the heart for the pulmonary veins and the coronary
sinuses, the body should be positioned in a recumbent
position toward the opposite side of the desired target;
for instance, a right lateral recumbent position is
required for the left pulmonary veins. The shaft was then
rotated and gently moved around the heart along the
pericardium.
For a clearer visualization of the narrow pericardial
space, air injection was the critical technique required, as
described in the previous paper [19]. The “air tamponade”
gave us enough space for handling the endoscopes. How-
ever, detention of the guide wire in the pericardial space
was also valuable in preserving the work space. The stiff
guide wires served as struts in the pericardium, similar to
pitching a tent. This procedure could reduce the amount
of air inside of the pericardial space, which resulted in
less risk of hemodynamic deterioration.
The images obtained from rigid pericardial endoscopes
were vivid enough to identify not only anatomical struc-
tures but also small branches of coronary vessels and
details of the heart tissue condition. Therefore, minor
surgery was able to be performed as follows.
Cell transplantation
There are no accepted minimally invasive techniques to
transplant cells into the myocardium for tissue engineer-
ing therapy; however, we have now established secure
and precise transplantation tools.
The double sheath approach enabled us to deliver for-
ceps and endoscopes to desired sites. A mixture of sili-
con beads, indocyanine green, fluoroscopic contrast, and
ultrasonographic contrast medium was transplanted to
demonstrate cell transplantation. After insertion of R-70
into Sh-S, Sh-L was inserted into the pericardium next
to Sh-S (Figure 2A). Nd-G operating through Sh-L was
delivered to a desired puncture site while avoiding small
coronary vessels (Figure 2B). The slight compression of
the heart by Nd-G did not cause a blood pressure drop
or ventricular arrhythmia; however, this helped to
stabilize the needle on the heart. By grasping the grip of
Nd-G, the needle protruded from the tip, and beads
were injected into the myocardium. The injection sites
were macroscopically confirmed by indocyanine green
and fluoroscopically by the contrast medium. The trans-
plantation was performed 20 times (Figure 2C). Nonsus-
tained ventricular tachycardia was observed during
injection without hemodynamic changes. The heart was
dissected after the session (Figure 2D), and successful
transmural transplantation was confirmed with slight
hemorrhage in the myocardium (Figure 2E, F). Minor















Figure 2 Demonstration of cell transplantation with needle with grip (Nd-G). A mixture of silicon beads, indocyanide green,
ultrasonographic and fluoroscopic contrast medium was injected into the myocardium by Nd-G. A: Two sheaths were inserted into the
pericardial space, Sh-S with R-70 and Sh-L with Nd-G. Coronary vessels such as the first diagonal branch (D1) were clearly visualized to avoid
injuries. B: Nd-G was inserted through Sh-L and placed at the puncture site while avoiding coronary vessels. C: Injections were performed 20
times (white arrows). Intraventricular injections due to strong motion artifacts caused a slight hemorrhage (Bld) that spontaneously stopped
without hemodynamic change. Macroscopic evaluation (D), a cross section of injected sites (E), and a cross section with fluorescence filter (F)
showed that the transmural injection was successfully performed in the anterolateral wall of the left ventricle. Bld: blood; LAA: left atrial
appendage; LAD: left anterior descending artery; LV: left ventricle; RAA: right atrial appendage; RV: right ventricle; Wire: a guide wire; Sh-L, Sh-S,
Nd-G; as described in Figure 1.
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minute without any hemodynamic change. Due to a
strong cardiac motion artifact, the risk of transmural
injection by an accidental intraventricular injection was
inevitable by using Nd-G. Therefore, we developed an
ultrasonography-guided transplant needle (Nd-U) to se-
cure the intramural injection. The target site of injection
was viewed by the rigid endoscope to avoid injury to the
coronary arteries (Figure 3A, B). The probe of the ultra-
sonography was then firmly attached to the surface of
the heart (Figure 3C). Ultrasonography gave sufficient in-
formation about the myocardium: myocardial thickness,
blood vessels, valve positions, and other anatomical char-
acteristics. Once the puncture site was securely con-
firmed by ultrasonography (Figure 3D), the needle was
introduced 3–5 mm from the probe (Figure 3E). The
needle was locked and prevented from protruding more
than 5 mm as a safety measure. After confirmation of theneedle position, the beads were slowly injected
(Figure 3F, G). The injected material appeared to be a
residue of the ultrasonographic contrast medium. There
was no risk of intraventricular injection and blood vessel
injury. This procedure enabled us to safely transplant
cells intramurally, even safer than open chest surgery.
Pacemaker lead implantation
Epicardial pacemaker leads are used for cardiac resyn-
chronizing therapy when the anatomy of the coronary
sinus is not suitable for the maximum pacing benefit,
which currently requires open chest surgery. Therefore,
we developed a methodology for minimally invasive
endoscopic epicardial pacemaker lead implantation.
For successful outcomes of left ventricular pacing, the
orientation of the lateral and posterior sides of the heart
is important. When the rigid endoscopes were advanced
to the top of the pericardium in a dorsal position, the
A B C



















Figure 3 Ultrasonography-guided cell transplantation. To avoid intracardial injections, we developed ultrasonography-guided needle forceps
(Nd-U). A: After a double sheath procedure, R-70 and Nd-U were inserted. B: The 23 Gauge needle was extended under ultrasonographic
guidance. C: Avoiding any coronary vessels, Nd-U was placed on the lateral wall of the left ventricle. D: An ultrasonographic image was useful in
determining anatomical orientations and major vessels at injection sites. E: The needle was extended from the upper right corner of this image.
F: Beads were securely injected in the myocardium by confirming the location of the tip of the needle. G: After injections, bead retention in the
myocardium was confirmed by a residue of ultrasonographic contrast medium. Be: a mixture of silicon beads and contrast medium; D1: first
diagonal branch; Intra: intra ventricle; LAA: left atrial appendage; LV: left ventricle; Ndl: needle; Nd-U as described in Figure 1.
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atrial appendage, the left circumflex coronary artery, and
the distal of the coronary sinus were able to be visua-
lized with the subject in a right lateral recumbent pos-
ition (Figure 4B). A clockwise rotation of the rigid
endoscope enabled us to observe the base of the
postero-lateral wall of the left ventricle, the inferior vena
cava, and the left pulmonary vein (Figure 4C). By pulling
the rigid endoscope toward the apex, the wide area of
postero-lateral wall of the left ventricle was observed
(Figure 4D). By properly managing appropriate body
positions, the whole heart could be observed and coron-
ary sinus-independent pacing sites could be selected
without requiring open chest surgery.
To demonstrate pericardial lead implantation, the
intraventricular pacemaker lead was securely implanted
at the base of the lateral wall of the left ventricle
(Figure 4E). The endoscope was held to observe the basal
free wall of the left ventricle. The lead was delivered by
the deflectable stylet and placed at the base of the left
ventricle under fluoroscopic guidance. The lead was
screwed into the myocardium without fatal arrhythmia,
hemodynamic change, or hemorrhage. Pacing from the
implanted lead was successfully performed, and there
were no signs of dislodging or pacing failures 30 min
after the implantation. Furthermore, the epicardial tem-
porary pacing lead was successfully implanted in theright ventricle (Figure 4F). The lead was delivered by a
needle holder through Sh-L, and pacing worked properly
(threshold 0.1 V/0.4 msec, sense >20 mV). The use of an
epicardial sutureless myocardial pacing lead was also
evaluated (Figure 4G). Although the implantation was
successful, the maneuver was difficult, and the pacing
condition was not sufficient (threshold: 5 V/0.4 msec,
sense: 4 mV). Because the device itself was designed for
open chest surgery, the outer diameter of the lead handle
was so large (14 mm) that it was not suitable for this ap-
proach. Further modification of the lead designed for a
rigid pericardial endoscope should be considered.
For implantation of epicardial pacing leads (Model
4968, Medtronic, Minneapolis, MN, USA), a suture at-
tempt was successfully performed using round needles
(3–0 Vicryl) and needle holders in Sh-L. This method
could be utilized for ligation of the coronary artery to
provide a myocardial infarction model for experimental
use (Figure 4H).
Applications for epicardial catheter ablation
Pulmonary veins are known as the site for initiating
atrial fibrillation [21]. We evaluated the possibility of iso-
lating the pulmonary vein by rigid pericardial endoscopy.
We successfully observed both sides of the pulmonary
veins by avoiding the lateral wall of the atrium and the
appendage. This was accomplished through the use of
B D



















Figure 4 Epicardial pacemaker lead implantation. To identify the best position of left ventricular pacing sites, establishing anatomical
orientations was critical. A: In the dorsal position, the right atrial appendage was confirmed by simply advancing the rigid endoscope toward the
top of the pericardium. B: In the right lateral recumbent position, the left atrial appendage (LAA), distal of the coronary sinus (CS) and left
circumflex artery (LCX) were clearly confirmed. C: By moving the rigid endoscope around the heart, the base of the postero-lateral wall of the left
ventricle, the inferior vena cava (IVC) and the left pulmonary vein (LPV) were also identified. D: By pulling the rigid endoscopes toward the apex,
a broad overview of the postero-lateral wall of the left ventricle, which was the appropriate epicardial pacing target in cardiac resynchronizing
therapy, was obtained. E: The intraventricular pacing lead with a deflectable stylet was securely implanted in the postero-lateral wall of the left
ventricle. F: The epicardial temporary pacing lead was implanted in the right ventricle (RV). G: An attempt was made to implant the epicardial
sutureless pacing lead; however, the device was too large (14 mm) and required modifications. H: A suture attempt was successfully performed
to fix the epicardial pacing leads. CS: coronary sinus; LAA: left atrial appendage; LCX: left circumflex artery; LPV: left pulmonary vein; LV: left
ventricle; PD: posterior descending artery; RAA: right atrial appendage; RV: right ventricle.
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recumbent position (Figure 5A, B). The pulmonary veins
were clamped by forceps without major injuries except
for nonsustained atrial fibrillation due to mechanically
stretching of the pulmonary veins (Figure 5C). A safe
clamp of the pulmonary veins can be a minimally inva-
sive alternative to an open chest Maze procedure.
Safety of pneumoperitoneum device
Stretching the pericardium with a rigid endoscope could
reduce the amount of air in the pericardium that is used
for clear visualization. However, filling the pericardial
space with air was efficient for this procedure. Similar to
laparoscopic surgery, we evaluated the safety of using a
continuous pressure-controlled carbon dioxide supply
device. The baseline intrapericardial pressure was 2
mmHg, and an additional 3–5 mmHg did not cause any
hemodynamic changes. However, an intrapericardial
pressure of 6 mmHg induced a sudden systolic pressure
drop of 10 mmHg. The fluoroscopy showed a remark-
able enlargement of the pericardium, swinging of the
heart, and collapse of the left lung. The total amount of
supplied air was 700 ml, which suggested that air had
leaked into the thoracic cavity and the mediastinum.
The pressure drop quickly recovered upon removal of
the air. The pressure-controlled air infusion device wasnot suitable for pericardial endoscopy and required
modifications for safe use.
Safety evaluation
As a promising minimally invasive approach to the peri-
cardial space, the safety of rigid pericardial endoscopy
was investigated. With regards to acute complications,
arterial blood pressure, and pulse oximetry data were
stable during the entire session except for during the use
of a continuous air supply device. Other mechanical in-
juries, such as major bleeding, pneumothorax, and fatal
arrhythmia were not identified during these sessions.
Discussion
Safer, easier, and clearer: The benefits compared to
flexible pericardial endoscopes
The pericardial approach by using rigid pericardial en-
doscopy was feasible for cell transplantation, pacemaker
lead implantation, and epicardial ablation. The efficient
use of flexible pericardial endoscopy was previously
reported [19]. The use of air to inflate the pericardial
space and fluoroscopic guidance of endoscopes along the
pericardium enabled us to perform minor surgery in the
pericardial space. Compared to flexible pericardial endos-
copy, rigid pericardial endoscopy uses smaller devices,







Figure 5 Applications for epicardial ablation. The rigid pericardial endoscope-assisted Maze procedure was evaluated. A: in the right lateral
recumbent position, the left atrial appendage (LAA) was confirmed. B: By avoiding LAA by a guide wire, the ostium of the left pulmonary vein
(LPV) was identified. C: The connection of the left atrium and the ostium of the LPV was securely clamped by forceps without major injury. D1:
first diagonal branch; LAA: left atrial appendage; LPV: left pulmonary vein.
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easier access to the posterior wall of the heart, and better
control of motion artifacts (Table 1). With regards to the
approach to the apex, a flexible pericardial endoscope
might be easier. Because the flexible pericardial endo-
scopes were turned around at the roof of the pericar-
dium, we were able to observe the apex in the “inverted
U-shape configuration”, as mentioned in the previous
paper [19]. The apical view using a rigid pericardial endo-
scope may lead to an unexpected extraction of the device
from the pericardial space, which was successfully
avoided by clamping the guide wire.
One of the complications caused by flexible pericardial
endoscopy was the air tamponade. For easier control, we
tried to use the pneumoperitoneum device. However,
because the device was maintained by pressure control,
the amount of air required was large. An air leak
could be lethal, inducing pneumomediastinum andTable 1 Comparisons between rigid and flexible
pericardial endoscopes
Rigid endoscope Flexible endoscope
Device size Smaller Larger
Manipulation Intuitive Fluoroscopy dependent
View Wider Position dependent











Motional artifact Fixed by forceps Reduced by forceps
Compared with flexible pericardial endoscopes, the smaller rigid pericardial
endoscopes are more advantageous. These devices are more intuitively
manipulated, offer a clearer and wider field of view, are easier to establish
orientation, offer easier access to the posterior wall of the heart including the
pulmonary veins, and are better at controlling motion artifacts. The use of less
air in the pericardial space through stretching the pericardium with rigid
endoscopes reduces the risk of complications.pneumothorax. Therefore, stretching the pericardium
with the rigid pericardial endoscopes and retaining the stiff
guide wire in the pericardium were more effective in estab-
lishing a visual field with a reduced dependence on air.
Future perspectives
Our study demonstrated that minor surgery for cell
transplantation, lead transplantation, and epicardial abla-
tion as assisted by rigid pericardial endoscopy was safe
and feasible (Additional file 1). Our methodology of cell
transplantation was as safe as open chest surgery. The
coronary vessels were avoided macroscopically, and the
depth of the needle and the details of the anatomy were
confirmed by ultrasonography. This method will soon be
performed in clinical practice and will be applicable for
gene transfer or cytokine administration. A direct injec-
tion of cells might injure the myocardium compared to
cell sheet delivery [22]; however, sheet delivery requires
open chest surgery. Although the effectiveness of cell
sheet delivery for the fat-rich human heart is still un-
known, the rigid pericardial endoscope could be applic-
able for delivering cell sheets less invasively. However,
minimally invasive delivery of devices into the pericardial
space is difficult, especially for fragile objects such as cell
sheets. Further experiments are necessary to explore al-
ternative delivery methods for cell-loaded devices. Once
the most effective method of cell transplantation is estab-
lished, this technology should be applicable for any of
these aforementioned applications.
Lead implantation using rigid pericardial endoscopy
was possible without any major complications. Because
the most appropriate site of lead transplantation in car-
diac resynchronizing therapy may not be possible via the
coronary sinus, a rigid pericardial endoscopic approach
could supply another minimally invasive option. Testing
3 kinds of pacing leads gave us enough information to
optimize a prototype for this procedure.
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monary veins could be clamped by forceps inserted from
the epicardial fossa. The same kind of manipulation was
previously performed by thoracoscopy [23]. The less in-
vasive Maze procedure could be performed by a rigid
pericardial endoscope. Endoscopic-guided epicardial ab-
lation is advantageous in obtaining gross information on
the surface of the heart, especially in cases of arrhythmo-
genic foci located in the epicaridum near a coronary ar-
tery or scar, which requires open chest surgery. Further
studies for complicated manipulation, such as penetrat-
ing the pericardium, and chronic complications, includ-
ing pulmonary vein stenosis, should be evaluated.
The recent report showed that transmural atrial gene
transfer by painting adenoviral vectors to the epicardial
surface was successful [24]. This methodology could be
applicable to rigid pericardial endoscopy for safer ma-
nipulation. The combination of gene therapy and rigid
pericardial endoscopy as a focal transgenic method
could cure refractory genetic arrhythmias and ionic
channel disorders.
Furthermore, the combination of pericardial endos-
copy and thoracoscopy under general anesthesia might
enable us to perform more complicated maneuvers;
however, that procedure would no longer be minimally
invasive. Approaching the epicardial space from the
esophagus could be a practical application of natural ori-
fice transluminal endoscopic surgery (NOTES) [25],
which could avoid injury to the esophagus during left
atrial ablation. Other devices, such as hemostatic
devices, suture devices, and epicardial pacemaker lead
kits, are now under development. This procedure might
be performed after cardiac surgery, and successful adhe-
siotomy of the pericardium would broaden its indica-
tions. We predict that the rigid pericardial endoscopy
technique in humans and the broadening of its indica-
tions are forthcoming.
Study limitations
The number of animals was too small to evaluate all of
the advantages and disadvantages of this procedure. Be-
cause swine and canines were used for this experiment,
the anatomical differences between the animal species
might result in differences in safety and efficacy. All of
the protocols were evaluated for acute complications.
Further studies were necessary to evaluate chronic com-
plications and the effectiveness of minor surgery. Fur-
thermore, the risk of infection in cell transplantation
and follow-up data of lead function in lead implantation
should also be evaluated.
Conclusions
Rigid pericardial endoscopy is a promising manipulation
procedure for minimally invasive cell transplantation,epicardial lead implantation, and epicardial ablation by
providing a safe and clear visual field in the pericardial
space.
Additional file
Additional file 1: Video: rigid pericardial endoscopy. A rigid
pericardial endoscope was inserted from the epicardial fossa to the
pericardial space. Atrial appendages, coronary sinus and pulmonary veins
were clearly identified. As the demonstration of cell transplantation,
silicon beads, indocyanide green, ultrasonographic and fluoroscopic
contrast medium were injected 20 times. Transient ventricular tachycardia
did not deteriorate hemodynamic conditions. The use of an
ultrasonography-attached needle was successful in avoiding
intraventricular injection. For pacemaker implantation, the left ventricular
free wall was clearly visualized in the left recombinant position. The
intraventricular pacemaker lead was successfully implanted, and the
epicardial sutureless lead and the suture trial were attempted. For
epicardial ablation, the left pulmonary vein was identified and clamped
by rigid forceps for the minimally invasive Maze procedure
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